Search Results

EchoGuide is a vascular ultrasound imaging device meant to aid in identification of the cannulation site on the skin of mature arteriovenous fistulas/grafts (AVFs/AVGs) in adult patients by appropriately trained healthcare providers in clinical settings. This device is not meant to replace the current standard of care cannulation methods.

EchoGuide is a 3D automated ultrasound solution designed to provide the benefits of ultrasound for arteriovenous fistula/graft cannulation without the need for extensive training. EchoGuide uses a three-dimensional probe to acquire live coronal plane images, in addition to automating imaging settings, to allow users to quickly assess the position, trajectory, and size of an arteriovenous fistula/graft. Users can then mark the position and trajectory of the access on the patient's skin before removing the probe and proceeding with cannulation.

The EchoGuide probe houses a 2D array on a track. The piezoelectric material in the transducer is used as an ultrasound source to transmit sound waves into the body. Sound waves are reflected back to the transducer and converted to electrical signals that are processed. The transducer is a 52 mm linear (192 element) motorized probe capable of capturing a volume of data. The motorized probe collects a series of 2D images to capture a volume. Through image analysis and processing, the volumes are sliced to create live coronal plane renderings.

The ultrasound system has a laptop form factor, with a bottom touch screen for user interaction and an additional top screen for display. The ultrasound system includes a transmitter and receiver, are all self-contained within the case. The ultrasound system interfaces with the probe through a port on the right side of the system.

The EchoGuide user interface defaults to a conventional 2D ultrasound image when the system powers on. Users can switch between this view, and the live coronal imaging via controls on the bottom screen of the ultrasound. Users can freeze the imaging and capture a snapshot of the fistula/graft as well. The snapshot displays a static view of the fistula/graft in the coronal and transverse planes.

EchoGuide is intended to be used in a clinical setting at the point of hemodialysis care.

This document primarily focuses on the FDA 510(k) clearance process for "EchoGuide (Version 1)" and its substantial equivalence to predicate devices, rather than a detailed report of a study proving the device meets specific performance acceptance criteria for an AI algorithm. The provided text touches on non-clinical and clinical testing but does not provide the granular details required to answer all parts of your request, particularly regarding specific performance metrics (e.g., sensitivity, specificity, accuracy), expert qualification for ground truth, and the specifics of AI-assisted human reader studies.

Here's an analysis based on the information provided, highlighting what can be discerned and what is missing:

Acceptance Criteria and Device Performance for EchoGuide (Version 1)

The provided FDA 510(k) clearance letter and summary primarily discuss the substantial equivalence of the EchoGuide device to existing predicate devices, focusing on its intended use, technological characteristics, and conformance to general safety and performance standards for imaging devices. It does not explicitly state acceptance criteria in terms of specific performance metrics (e.g., sensitivity, specificity, accuracy for identifying cannulation sites) for an AI component.

The document mentions "imaging accuracy and quality" as confirmed by a clinical study, but without providing the quantitative acceptance criteria or the reported performance values against these criteria.

Missing Information:

• A specific table of acceptance criteria for AI-driven performance metrics (e.g., a specific target sensitivity or accuracy).
• Reported device performance values against these specific AI-driven criteria. The text only vaguely states "confirms the imaging accuracy and quality of EchoGuide for in vivo use."

Study Details (Based on available information):

1. Table of Acceptance Criteria and Reported Device Performance:

As noted above, this level of detail is not provided in the given FDA 510(k) document. The document focuses on showing substantial equivalence and conformance to general device standards.

2. Sample Size and Data Provenance for Test Set:

• Sample Size: The document states, "Data from a non-significant risk observational study was used to confirm in vivo imaging adequacy of EchoGuide for the exam of hemodialysis accesses." It further specifies that "Images were collected on upper arm arteriovenous fistulae." However, the exact sample size (number of patients or images) for this "test set" is not specified.
• Data Provenance: The study was described as a "prospective, single arm, non-randomized, observational study." The country of origin is not explicitly stated, but given the FDA clearance, it's highly likely to be US data or data suitable for US regulatory submission.

3. Number and Qualifications of Experts for Ground Truth:

• The document does not provide any information on the number of experts used to establish ground truth or their specific qualifications (e.g., "Radiologist with X years of experience").
• It mentions the device is "meant to aid in identification of the cannulation site...by appropriately trained healthcare providers in clinical settings," but doesn't detail how the 'true' cannulation sites were established for the study.

4. Adjudication Method:

• The document does not provide any information on the adjudication method used for establishing ground truth (e.g., 2+1, 3+1 consensus).

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

• The document does not describe a multi-reader multi-case (MRMC) comparative effectiveness study comparing human readers with and without AI assistance. The focus is on the device's imaging quality for in vivo use.
• Therefore, there is no information on the effect size of how much human readers improve with AI vs. without AI assistance.

6. Standalone (Algorithm-Only) Performance:

• The device is described as an "ultrasound solution designed to provide the benefits of ultrasound for arteriovenous fistula/graft cannulation" and automates "imaging settings" to allow users to "assess the position, trajectory, and size." It also states, "EchoGuide is a vascular ultrasound imaging device meant to aid in identification of the cannulation site...by appropriately trained healthcare providers."
• This phrasing suggests that the device (likely including algorithmic processing for image presentation and perhaps automated measurements/guidance, but without explicit AI claims) is intended to be used by a human operator to assist in a task. It is not presented as a standalone diagnostic algorithm that outputs a decision on its own.
• The document does not explicitly describe a standalone ("algorithm-only") performance study in terms of metrics like sensitivity, specificity, or AUC as one might see for a diagnostic AI. The "imaging accuracy and quality" mentioned is likely related to the visual representation and utility for a human user.

7. Type of Ground Truth Used:

• The document refers to a "non-significant risk observational study" where "Images were collected on upper arm arteriovenous fistulae." The study's primary objective was "data collection." It confirms "in vivo imaging adequacy."
• The nature of the ground truth is not explicitly stated beyond being related to "in vivo imaging adequacy" for "hemodialysis accesses." For specific "identification of the cannulation site," ground truth could potentially involve:
  • Expert consensus (e.g., radiologists/sonographers outlining the vessel)
  • Pathology (unlikely for this application)
  • Outcomes data (e.g., successful cannulation rates after using the device, but this is usually a separate clinical utility study)
  • Perhaps direct measurements or annotations from images performed by clinicians in the study.
• The specific method for establishing the 'true' cannulation site or vessel parameters is not detailed.

8. Sample Size for Training Set:

• The document describes a clinical evaluation/validation study, but it does not provide information on the sample size of any training set used for the development of the EchoGuide's algorithms (if it uses machine learning/AI models). This information is typically found in design validation documentation, not necessarily in the public 510(k) summary focused on substantial equivalence.

9. How Ground Truth for Training Set Was Established:

• Since information on a training set is not provided, there is no information on how ground truth for such a set would have been established.

Summary of Missing Information Critical for Full Response:

The provided document, being a 510(k) clearance letter and summary, primarily focuses on demonstrating substantial equivalence to predicate devices and adherence to general performance standards, rather than providing a detailed clinical study report for an AI-driven device with specific performance metrics against pre-defined acceptance criteria. Therefore, many of the specific details requested regarding AI performance studies, sample sizes, expert qualifications, and ground truth establishment are not present in this particular type of FDA document.

Ask a specific question about this device